Cerebral blood flow and metabolism in fulminant liver failure
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Fulminant liver failure is a syndrome that is frequently complicated by cerebral edema and increased intracranial pressure. Cerebral blood flow has been reported as high in some studies but low in others. This study undertook to measure cerebral blood flow and cerebral metabolic rate for oxygen in 30 patients with fulminant liver failure in grade 4 encephalopathy and to assess these parameters after intervention with hyperventilation and infusions of mannitol, epoprostenol and acetylcysteine. Cerebral blood flow varied widely, from 14 to 71 ml/100 gm/min (normal range, 41 to 66), whereas the cerebral metabolic rate for oxygen was low in all patients, 0.16 to 2.03 ml/100 gm/min (normal range, 3.12 to 3.96). Twenty-one of the 30 patients had evidence of anaerobic metabolism with cerebral lactate production. Hyperventilation resulted in a significant decrease in both cerebral blood flow (median, 36 to 28 ml/100 gm/min) and cerebral metabolic rate for oxygen (median, 0.92 to 0.65 ml/100 gm/min); mannitol and acetylcysteine infusions resulted in significant increases in both of these parameters. Prostaglandin I 2 infusion did not significantly alter cerebral blood flow, but there was a significant increase in cerebral metabolic rate for oxygen. The depressed cerebral metabolic rate for oxygen in patients with fulminant liver failure is inappropriate to metabolic requirements, as demonstrated by both cerebral lactate production and the increase in cerebral oxygen consumption after improvement in cerebral blood flow. Mannitol infusion should remain the main treatment of the cerebral complications of fulminant liver failure. Acetylcysteine has a beneficial effect that is not restricted to fulminant liver failure after acetaminophen overdose and has a role in the management of patients, regardless of cause of illness. The use of prostaglandin I 2 appears to be safe and may be beneficial. Acute hyperventilation causes decreases in both cerebral blood flow and cerebral metabolic rate for oxygen and has the potential to worsen cerebral ischemia. (Hepatology 1994;19:1407-1413.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These effects include non-specific antioxidant effects, preservation of cerebral blood flow and perfusion in cerebral edema after liver failure (224).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [224]
Citations
Cites
Greenberg, H. B. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170210085033 · Cited by 848
The management of fulminant hepatic failure.
Trey, C., & Davidson, C. S. (1970) · PubMed · Cited by 642
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585 · cited 3×
“Infusions of prostaglandin I, (PGI,) and acetylcysteine were also investigated because they have been shown to effectively reverse systemic oxygen debt in FLF (8).”
BackgroundSelf-citationBihari, D., Smithies, M., Gimson, A., & Tinker, J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170701 · Cited by 554
Powers, W. J., Grubb, R. L., Darriet, D., & Raichle, M. E. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.89 · Cited by 425
Muizelaar, J. P., Marmarou, A., DeSalles, A. A. F., Ward, J. D., Zimmerman, R. S., Li, Z., Choi, S. C., & Young, H. F. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.71.1.0063 · Cited by 331
Cerebral Edema: A Major Complication of Massive Hepatic Necrosis
Ware, A. J., D’Agostino, A. N., & Combes, B. (1971) · Gastroenterology · doi:10.1016/s0016-5085(19)33402-x · Cited by 267
SULFHYDRYL REQUIREMENT FOR RELAXATION OF VASCULAR SMOOTH MUSCLE
Needleman, P., Jakschik, B., & Johnson, E. M. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29678-1 · Cited by 250
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.
Stamler, J., Mendelsohn, M. E., Amarante, P., Smick, D., Andon, N., Davies, P. F., Cooke, J. P., & Loscalzo, J. (1989) · Circulation Research · doi:10.1161/01.res.65.3.789 · Cited by 244
Wei, E. P., Kontos, H. A., Christman, C. W., DeWitt, D. S., & Povlishock, J. T. (1985) · Circulation Research · doi:10.1161/01.res.57.5.781 · Cited by 202
Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure
Ede, R. J., Gimson, A. E. S., Bihari, D., & Williams, R. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80007-1 · Cited by 180
Self-citationCerebral blood flow and metabolism in man following cardiac arrest.
Beckstead, J. E., Tweed, W. A., Lee, J., & MacKeen, W. L. (1978) · Stroke · doi:10.1161/01.str.9.6.569 · Cited by 136
Tissue hypoxia during fulminant hepatic failure
BIHARI, D., GIMSON, A. E. S., WATERSON, M., & WILLIAMS, R. (1985) · Critical Care Medicine · doi:10.1097/00003246-198512000-00010 · Cited by 123
Self-citationLactic acidosis in fulminant hepatic failure
Bihari, D. J., Gimson, A. E., Lindridge, J., & Williams, R. L. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80778-9 · Cited by 108
Self-citationAlmdal, T., Schroeder, T. V., & Ranek, L. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909093050 · Cited by 74
Davenport, A., Will, E. J., & Davison, A. M. (1990) · Critical Care Medicine · doi:10.1097/00003246-199003000-00008 · Cited by 74
The effect of mannitol on cerebral blood flow
Jafar, J. J., Johns, L., & Mullan, S. F. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.64.5.0754 · Cited by 71
The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis
Bihari, S., & Tinker, J. (1988) · Intensive Care Medicine · doi:10.1007/bf00255627 · Cited by 70
Keays, R. T., Potter, D., O’Grady, J., Peachey, T., Alexander, G., & Williams, R. H. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068562 · Cited by 60
Self-citationSeda, H., Hughes, R. D., Gove, C. D., & Williams, R. L. (1984) · Hepatology · doi:10.1002/hep.1840040113 · Cited by 52
Self-citationBerk, P. D., & Popper, H. (2012) · SpringerReference · doi:10.1007/springerreference_301406 · Cited by 37
Wood, K. S., & Ignarro, L. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61148-2 · Cited by 34
Schroeder, T. V., Holstein, P., Lassen, N. A., & Engell, H. C. (1986) · Neurological Research · doi:10.1080/01616412.1986.11739761 · Cited by 29
Cold, G. E. (1986) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1986.tb02452.x · Cited by 26
Trewby, P., Hanid, M. A., Mackenzie, R. L., Mellon, P. J., & Williams, R. L. (1978) · Gut · doi:10.1136/gut.19.11.999 · Cited by 25
Self-citationDihydralazine induces marked cerebral vasodilation in man
Schroeder, T. V., & Sillesen, H. H. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01238.x · Cited by 23
Cerebrovascular reactivity to CO2 in patients with hepatic or septic encephalopathy
Sari, A., Yamashita, S., Ohosita, S., Ogasahara, H., Yamada, K., Yonei, A., & Yokota, K. (1990) · Resuscitation · doi:10.1016/0300-9572(90)90035-d · Cited by 23
Ede, R. J., Gove, C. D., Hughes, R. D., Marshall, W., & Williams, R. L. (1987) · Clinical Science · doi:10.1042/cs0720365 · Cited by 23
Self-citationBrain Energy Metabolism in Hepatic Encephalopathy
Hawkins, R. A., & Mans, A. M. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4506-3_11 · Cited by 21
Management options in fulminant hepatic failure.
Dj, K., Aggarwal, S., Martín, M. G., Darby, J., Obrist, W. D., Rosenbloom, A. J., Murray, G. R., Linden, P., & Miro, A. M. (1991) · PubMed · Cited by 17
Research works printed but not linked: 5
- Kramer, 1991, Transplant Proc, 23, 1895
- Robin, 1980, Am Rev Respir Dis, 122, 517
- Needleman, 1973, J Pharmacol Exp Ther, 187, 324
- Berk, 1978, Am J Gastroenterol, 69, 349
- Keays, 1991, Q J Med, 79, 425
Cited by
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Self-citationParacetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
“These effects include non-specific antioxidant effects, preservation of cerebral blood flow and perfusion in cerebral edema after liver failure (224).”
BackgroundFelipo, V., & Butterworth, R. F. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00019-9 · Cited by 618
Treatment of Hepatic Encephalopathy
Riordan, S. M., & Williams, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370707 · Cited by 489
Self-citationStravitz, R. T., Kramer, A. H., Davern, T., Shaikh, A. O. S., Caldwell, S. H., Mehta, R. L., Blei, A. T., Fontana, R. J., McGuire, B. M., Rossaro, L., et al. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000287592.94554.5f · Cited by 422
“However, prophylactic hyperventilation is not recommended in patients with ALF, because vasoconstriction can reduce cerebral oxygen utilization (94) and had no effect on the development of cerebral edema in one study (97).”
BackgroundMethod
Metadata
- Authors
- Wendon, J. A., Harrison, P. M., Keays, R., & Williams, R.
- Affiliations
- King's College London (GB)
- Corresponding author
- Williams, Roger
- Venue
- Hepatology
- Published
- 1994-06
- Volume
- 19
- Issue
- 6
- Pages
- 1407-1413
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2160749102
- Cited by
- 220
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 1 · 2014: 3 · 2013: 5 · 2012: 9
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 7762 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- acute liver failure, cerebral blood flow, cerebral oxygen consumption, hepatic encephalopathy, cerebral edema, intracranial pressure, hyperventilation, mannitol, N-acetylcysteine, epoprostenol, prostacyclin, cerebral ischemia
- MeSH terms
- Acetaminophen, Acetylcysteine, Adult, Blood Flow Velocity, Brain, Brain Edema, Female, Glucose, Hepatic Encephalopathy, Hepatitis, Viral, Human, Humans, Lactates, Male, Mannitol, Middle Aged, Oxygen, Epoprostenol, Regional Blood Flow, Respiration, Artificial, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.